Literature DB >> 11570630

Low levels of insulin-like growth factor-I in cerebrospinal fluid in children with autism.

R Vanhala1, U Turpeinen, R Riikonen.   

Abstract

Autism is a behaviourally defined syndrome characterized by disturbances of social interaction and communication and restrictions of behaviour patterns and imagination. The pathogenesis of autism is unknown but it is suspected that a number of genetic factors may be involved. Neurotrophic factors such as insulin-like growth factor-I (IGF-I) play a role in early brain development. The aim of this study was to determine whether IGF-I levels might be associated with the development of autism. IGF-I levels were measured in the CSF of 11 children with autism (4 females, 7 males; mean age 3.8 years, SD 1.1) using a sensitive radioimmunoassay method and compared with levels in 11 control participants (6 females, 5 males; mean age 3.8 years). Levels of IGF-I in the CSF were statistically significantly lower in the children with autism than in the control children (p=0.03). IGF-I may play a role in pathogenetic mechanisms of autism and the role of neurotrophic factors in autism and other neurodevelopmental diseases should be studied further.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11570630     DOI: 10.1017/s0012162201001116

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  16 in total

Review 1.  The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.

Authors:  Jesse Costales; Alexander Kolevzon
Journal:  Neurosci Biobehav Rev       Date:  2016-01-15       Impact factor: 8.989

2.  Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism.

Authors:  Adrian L Oblak; Terrell T Gibbs; Gene J Blatt
Journal:  J Neurochem       Date:  2010-06-12       Impact factor: 5.372

3.  Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in children with autism spectrum disorder.

Authors:  Zheng Li; Gui-Yuan Xiao; Chun-Yan He; Xia Liu; Xin Fan; Yan Zhao; Nian-Rong Wang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-02-15

4.  Comparison of Serum VEGF, IGF-1, and HIF-1α Levels in Children with Autism Spectrum Disorder and Healthy Controls.

Authors:  Fulya Şimşek; Ümit Işık; Evrim Aktepe; Faruk Kılıç; Fevziye Burcu Şirin; Mustafa Bozkurt
Journal:  J Autism Dev Disord       Date:  2021-01-03

5.  Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders.

Authors:  Hendrik Wesseling; Paul C Guest; Chi-Ming Lee; Erik Hf Wong; Hassan Rahmoune; Sabine Bahn
Journal:  Mol Autism       Date:  2014-07-04       Impact factor: 7.509

6.  Association between IRS1 Gene Polymorphism and Autism Spectrum Disorder: A Pilot Case-Control Study in Korean Males.

Authors:  Hae Jeong Park; Su Kang Kim; Won Sub Kang; Jin Kyung Park; Young Jong Kim; Min Nam; Jong Woo Kim; Joo-Ho Chung
Journal:  Int J Mol Sci       Date:  2016-07-29       Impact factor: 5.923

Review 7.  Insulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children.

Authors:  Raili Riikonen
Journal:  Int J Mol Sci       Date:  2017-09-26       Impact factor: 5.923

8.  Consumption of Breast Milk Is Associated with Decreased Prevalence of Autism in Fragile X Syndrome.

Authors:  Cara J Westmark
Journal:  Nutrients       Date:  2021-05-24       Impact factor: 5.717

9.  GH Dysfunction in Engrailed-2 Knockout Mice, a Model for Autism Spectrum Disorders.

Authors:  Giovanni Provenzano; Elena Clementi; Sacha Genovesi; Manuela Scali; Prem Prakash Tripathi; Paola Sgadò; Yuri Bozzi
Journal:  Front Pediatr       Date:  2014-09-01       Impact factor: 3.418

10.  Serum concentrations of insulin-like growth factor-1 as a biomarker of improved circadian rhythm sleep-wake disorder in school-aged children.

Authors:  Shigemi Kimura; Makiko Toyoura; Yuko Toyota; Yutaka Takaoka
Journal:  J Clin Sleep Med       Date:  2020-12-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.